Skip to main content
Premium Trial:

Request an Annual Quote

Axela Acquires Xceed Molecular

NEW YORK (GenomeWeb News) – Axela today announced that it has acquired Xceed Molecular for an undisclosed sum.

The deal combined Axela's multiplex protein biomarker testing capabilities with Xceed's Ziplex System for gene expression analysis. Axela said that the new firm, which will operate under its name, will offer clinical researchers a portfolio of products for analysis of proteins, pathogens, DNA, and RNA to speed the validation and clinical application of biomarkers.

Axela CEO Rocky Ganske will serve in the same role for the newly combined firm, which will now be located at Xceed's headquarters in Toronto.

Ganske said the acquisition of Xceed "provides a tremendous opportunity to accelerate introduction of novel multiplex biomarkers for diagnostics. Our focus is to simplify multiplex assay development and validation with robust, easy-to-use tools for analysis of DNA, RNA, and protein biomarkers that are designed to move seamlessly from the clinical-research arena into the workflow of the clinical-diagnostics lab."

Xceed President and CEO David Deems will become president of Axela and oversee sales, marketing, and business development. Deems said in a statement that the complementary technologies are "well-positioned to improve diagnostics in infection, cancer, and other immune-related diseases."

The firms are introducing the new Axela at the 2010 American Association of Clinical Chemistry annual meeting, which is taking place this week in Anaheim, Calif.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.